DrugPatentWatch Database Preview
Chartwell Molecules Company Profile
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty approved drugs.
Summary for Chartwell Molecules
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 20 |
Drugs and US Patents for Chartwell Molecules
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecules | DISULFIRAM | disulfiram | TABLET;ORAL | 091563-002 | Dec 31, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Chartwell Molecules | SELEGILINE HYDROCHLORIDE | selegiline hydrochloride | TABLET;ORAL | 074641-001 | Aug 2, 1996 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Molecules | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | TABLET;ORAL | 074093-002 | Nov 5, 1992 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Chartwell Molecules | ACYCLOVIR | acyclovir | TABLET;ORAL | 074834-001 | Apr 24, 1997 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
